MENU
NGNE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Neurogene (NGNE) Ownership - Who owns Neurogene?
Profile
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
336.31M
P/E Ratio
N/A
Total Cash
138.99M
Projected Growth
N/A
Total Debt
14.53M
Revenue
925K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.36
Total Debt/Equity
N/A
Revenue/Share
0.07 USD as % of share price
Fundamentals
NGNE
Capitalization
336M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
139M
Total Cash/Share
9.36
Total Debt
14.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.07%
Revenue
925K
ROE
N/A
Book Value
137M
P/B Ratio
2.45
Cash Flow
N/A
Earnings
-4.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
9.09
Current Revenue Per Employee
10164.83
Dividends Per Share - Security
N/A
EBITDA
-49.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.44
Shares Held By Institutions
828M
Shares Outstanding - Current
14.9M
Total Liabilities
26.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
16.821
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
535 W 24th Street
Phone
+1 855 508-3568
Employees
91
Web
https://www.neurogene.com